EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

STN1 upregulation promotes PARPi resistance in BRCA2-deficient cancer cells via replication fork protection and suppression of ssDNA gap formation

Zubair Ahmed Laghari, Na Li, Serdar Gayybov, Qi-En Wang iD, Weihang Chai iD

NAR Cancer · 2026

DOI: 10.1093/narcan/zcag023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, 2026. Verfasst von Zubair Ahmed Laghari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genetic Diseases, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, United States. Hauptthemen laut MEDLINE: BRCA2 Protein, Drug Resistance, Neoplasm, DNA Replication, DNA, Single-Stranded. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PARPi are effective therapy for BRCA1/2 mutant cancers, yet recurrent PARPi resistance frequently develops. The underlying mechanism of PARPi resistance remains largely unresolved. Here, we identify STN1, a component of the CTC1/STN1/TEN1 (CST) complex, as a modulator of PARPi resistance in BRCA2-deficient cells. RNA sequencing (RNA-seq) analysis of PARPi-resistant cancer cells from BRCA2-mutated backgrounds shows largely distinct transcriptomic profiles with limited overlap, suggesting multiple routes to resistance. Notably, STN1 is consistently upregulated in resistant cells. We observe that overexpression of STN1 enhances olaparib resistance in multiple BRCA2-deficient cell lines and alleviates DNA damage under replication stress. Mechanistically, we find that STN1 overexpression increases RAD51 loading to stalled replication forks while restricting MRE11 recruitment in BRCA2-deficient cells, thereby protecting stalled forks from nascent-strand degradation. Furthermore, STN1 overexpression rescues the accumulation of single-stranded DNA (ssDNA) gaps, a major determinant of PARPi sensitivity in BRCA2-deficient cells. Taken together, these findings suggest that elevated STN1 levels can partially compensate for BRCA2 loss by stabilizing stalled replication forks and limiting ssDNA gap accumulation. Our study uncovers a STN1-dependent pathway of replication stress tolerance that promotes PARPi resistance, highlighting STN1 as a potential biomarker and mechanistic contributor to therapeutic resistance in BRCA2-mutated cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA2 ProteinDrug Resistance, NeoplasmDNA ReplicationDNA, Single-StrandedTelomere-Binding ProteinsHumansUp-RegulationCell Line, TumorDNA DamageGene Expression Regulation, Neoplastic

Substanzen

BRCA2 ProteinBRCA2 protein, humanDNA, Single-StrandedTelomere-Binding Proteins

Autor:innen und Institutionen

  • Center for Genetic Diseases, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, United States.
  • Department of Radiation Oncology, The Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, United States.

ORCID-Profile: Qi-En Wang, Weihang Chai

Förderung

  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Laghari, Z. A., Li, N., Gayybov, S., Wang, Q. E., & Chai, W. (2026). STN1 upregulation promotes PARPi resistance in BRCA2-deficient cancer cells via replication fork protection and suppression of ssDNA gap formation. NAR Cancer. https://doi.org/10.1093/narcan/zcag023

Vancouver

Laghari ZA, Li N, Gayybov S, Wang QE, Chai W. STN1 upregulation promotes PARPi resistance in BRCA2-deficient cancer cells via replication fork protection and suppression of ssDNA gap formation. NAR Cancer. 2026. doi:10.1093/narcan/zcag023

BibTeX
@article{Laghari2026,
  author = {Laghari, Zubair Ahmed and Li, Na and Gayybov, Serdar and Wang, Qi-En and Chai, Weihang},
  title = {STN1 upregulation promotes PARPi resistance in BRCA2-deficient cancer cells via replication fork protection and suppression of ssDNA gap formation},
  journal = {NAR Cancer},
  year = {2026},
  doi = {10.1093/narcan/zcag023}
}
Kostenlos starten →